Eddy Anglade, M.D.
Chief Medical Officer
4
0
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Thomas Ciulla, MD
Clearside Biomedical, Inc.
Shared therapeutic areas:
Thomas Cuilla, MD, MBA
Clearside Biomedical, Inc.
Shared therapeutic areas:
Quan D Nguyen, MD, MSc
Johns Hopkins University
Shared therapeutic areas:
Jennifer E Thorne, MD, PhD
Department of Ophthalmology, Johns Hopkins School of Medicine,
Shared therapeutic areas:
Glenn J Jaffe, MD
Duke University
Shared therapeutic areas:
Kanjiro Masudo
Director, Kanto Rosai Hospital
Shared therapeutic areas:
Nathalie Mesnard
Allergan
Shared therapeutic areas:
Alexandra Wexler, Dr
Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
Shared therapeutic areas:
Nisha Acharya, MD, MS
UCSF, Proctor Foundation
Shared therapeutic areas:
Antonio Cutino
Alimera Sciences Inc
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis
Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis
All 4 trials loaded